|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
|
|---|---|---|---|---|---|
| Assets | |||||
| Current assets | |||||
| Cash and cash equivalents | |||||
| Marketable securities | |||||
| Short-term investments | |||||
| Prepaid expenses and other current assets | |||||
| Total current assets | |||||
| Operating lease right-of-use assets, net | |||||
| Property and equipment, net | |||||
| Restricted cash | |||||
| Total assets | |||||
| Liabilities and stockholders' equity | |||||
| Current liabilities | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Operating lease liabilities, current | |||||
| Total current liabilities | |||||
| Derivative liability - warrants | |||||
| Operating lease liabilities, noncurrent | |||||
| Total liabilities | |||||
| Preferred stock , Value | |||||
| Stockholders' equity | |||||
| Common stock, $0.0001 par value, 500,000,000 shares authorized, 32,269,691 and 25,299,372 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively. | |||||
| Additional paid-in capital | |||||
| Accumulated deficit | |||||
| Accumulated other comprehensive (loss) income | |||||
| Total stockholders' equity | |||||
| Total liabilities and stockholders' equity |
Loading...